Aardvark Therapeutics, Inc.

Aardvark Therapeutics, Inc. financial statements

Aardvark Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 010-K
Net income−USD 57.59M10-K
Cash and equivalentsUSD 47.05M10-Q
Total debtUSD 441KEODHD

Aardvark Therapeutics, Inc. financials on 6ix · Aardvark Therapeutics, Inc. on 6ix